490 related articles for article (PubMed ID: 31968655)
21. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis.
Gunn PJ; Pramfalk C; Millar V; Cornfield T; Hutchinson M; Johnson EM; Nagarajan SR; Troncoso-Rey P; Mithen RF; Pinnick KE; Traka MH; Green CJ; Hodson L
Physiol Rep; 2020 Jul; 8(13):e14482. PubMed ID: 32643289
[TBL] [Abstract][Full Text] [Related]
22. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
23. Metabolic-associated fatty liver disease and lipoprotein metabolism.
Heeren J; Scheja L
Mol Metab; 2021 Aug; 50():101238. PubMed ID: 33892169
[TBL] [Abstract][Full Text] [Related]
24. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
25. Ethanol exposure depletes hepatic pigment epithelium-derived factor, a novel lipid regulator.
Chung C; Shugrue C; Nagar A; Doll JA; Cornwell M; Gattu A; Kolodecik T; Pandol SJ; Gorelick F
Gastroenterology; 2009 Jan; 136(1):331-340.e2. PubMed ID: 18996124
[TBL] [Abstract][Full Text] [Related]
26. O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36.
Zhu H; Zhao T; Zhao S; Yang S; Jiang K; Li S; Kang Y; Yang Z; Shen J; Shen S; Tao H; Xuan J; Yang M; Xu B; Wang F; Jiang M
Metabolism; 2024 Jul; 156():155914. PubMed ID: 38642829
[TBL] [Abstract][Full Text] [Related]
27. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia.
Notari L; Miller A; Martínez A; Amaral J; Ju M; Robinson G; Smith LE; Becerra SP
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2736-47. PubMed ID: 16043845
[TBL] [Abstract][Full Text] [Related]
28. OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.
Akie TE; Liu L; Nam M; Lei S; Cooper MP
PLoS One; 2015; 10(5):e0125617. PubMed ID: 25933096
[TBL] [Abstract][Full Text] [Related]
29. Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells.
Ho TC; Chen SL; Shih SC; Wu JY; Han WH; Cheng HC; Yang SL; Tsao YP
Am J Pathol; 2010 Oct; 177(4):1798-811. PubMed ID: 20709803
[TBL] [Abstract][Full Text] [Related]
30. Pigment epithelium-derived factor may induce antidepressant phenotypes in mice by the prefrontal cortex.
Bai M; Yu H; Chen C; Xu X; He Y; Wang Y; Tian Y; Wu Z; Lan T; Li Y; Chen X; Chen Z; Zhao L; Fang L; Yang D; Cheng K; Xie P
Neurosci Lett; 2022 Feb; 771():136423. PubMed ID: 34965441
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
32. Hydrogen peroxide stimulates pigment epithelium-derived factor gene and protein expression in the human hepatocyte cell line OUMS-29.
Nakamura K; Yamagishi S; Yoshida T; Matsui T; Imaizumi T; Inoue H; Sata M
J Int Med Res; 2007; 35(3):427-32. PubMed ID: 17593873
[TBL] [Abstract][Full Text] [Related]
33. PEDF regulates plasticity of a novel lipid-MTOC axis in prostate cancer-associated fibroblasts.
Nardi F; Fitchev P; Franco OE; Ivanisevic J; Scheibler A; Hayward SW; Brendler CB; Welte MA; Crawford SE
J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29792311
[TBL] [Abstract][Full Text] [Related]
34. Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization.
Cheng J; Liu C; Hu K; Greenberg A; Wu D; Ausman LM; McBurney MW; Wang XD
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2783-2790. PubMed ID: 28789977
[TBL] [Abstract][Full Text] [Related]
35. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
36. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
37. Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.
Choi YJ; Lee CH; Lee KY; Jung SH; Lee BH
Toxicol Sci; 2015 Jun; 145(2):273-82. PubMed ID: 25745068
[TBL] [Abstract][Full Text] [Related]
38. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
[TBL] [Abstract][Full Text] [Related]
39. Pigment epithelium-derived factor (PEDF) suppresses IL-1β-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling.
Gattu AK; Birkenfeld AL; Iwakiri Y; Jay S; Saltzman M; Doll J; Protiva P; Samuel VT; Crawford SE; Chung C
Endocrinology; 2014 Apr; 155(4):1373-85. PubMed ID: 24456163
[TBL] [Abstract][Full Text] [Related]
40. ATGL Promotes Autophagy/Lipophagy via SIRT1 to Control Hepatic Lipid Droplet Catabolism.
Sathyanarayan A; Mashek MT; Mashek DG
Cell Rep; 2017 Apr; 19(1):1-9. PubMed ID: 28380348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
